Form 4 for MPLT MapLight Therapeutics, Inc.

Accepted 2026-06-25 17:54:43 ET · period of report 2026-06-23 · accession 0001470798-26-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-06-25 17:54	2026-06-23	MPLT	Pavlov George	Dir	A - Grant	$0.00	+3,932	28.9K	+16%	$0
D	2026-06-25 17:54	2026-06-23	MPLT	Pavlov George	Dir	A - Grant	$0.00	+14.9K	14.9K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Voting Common Stock	2026-06-23	A	A	3,932	$0.00	28,932	D	—	—	(F1) Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. (F2) Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
2	Derivative	Stock Option (right to buy)	2026-06-23	A	A	14,902	$0.00	14,902	D	$28.64 · — to 2036-06-22	14,902 Voting Common Stock	(F3) Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.